BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 4694816)

  • 1. Reutilization of thymidine and iododeoxyuridine by mouse mammary carcinoma strain MTG-B 1 .
    Clifton KH; Cooper JM
    Proc Soc Exp Biol Med; 1973 Apr; 142(4):1145-51. PubMed ID: 4694816
    [No Abstract]   [Full Text] [Related]  

  • 2. Reutilization of labelled-thymidine and -iododeoxyuridine for nuclear and mitochondrial DNA synthesis in regenerating rat liver.
    Baugnet-Mahieu L; Goutier R
    Arch Int Physiol Biochim; 1972 Apr; 80(2):319-30. PubMed ID: 4114879
    [No Abstract]   [Full Text] [Related]  

  • 3. Cell population growth and cell loss in the MTG-B mouse mammary carcinoma.
    Clifton KH; Yatvin MB
    Cancer Res; 1970 Mar; 30(3):658-64. PubMed ID: 5425291
    [No Abstract]   [Full Text] [Related]  

  • 4. An evaluation of radioiodine-labeled 5-iodo-2'-deoxyuridine as a tracer for measuring cell loss from solid tumors.
    Dethlefsen LA
    Cell Tissue Kinet; 1971 Mar; 4(2):123-38. PubMed ID: 5128277
    [No Abstract]   [Full Text] [Related]  

  • 5. The influence of exogenous thymidine concentration on the incorporation of labelled thymidine and iododeoxyuridine, and on growth of JU56 cells in vitro.
    Moore RC; Martin RF; Hodgson GS
    Aust J Exp Biol Med Sci; 1973 Apr; 51(2):169-79. PubMed ID: 4736769
    [No Abstract]   [Full Text] [Related]  

  • 6. Reutilization of DNA catabolites in granulocytopoiesis.
    Gerecke D; Gross R
    Blut; 1975 Jul; 31(1):43-8. PubMed ID: 1148404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reutilization of 125I-UdR during growth of a solid mammary carcinoma: implications for the 125I-UdR loss technique.
    Porschen R; Porschen W; Mühlensiepen H; Feinendegen LE
    Strahlenther Onkol; 1987 Nov; 163(11):723-8. PubMed ID: 3686335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physiological thymidine reutilization in rat bone marrow.
    Feinendegen LE; Bond VP; Hughes WL
    Proc Soc Exp Biol Med; 1966 Jun; 122(2):448-55. PubMed ID: 5980552
    [No Abstract]   [Full Text] [Related]  

  • 9. [Studies on the incorporation of exogenic DNA in mammalian cells].
    Friedrich G; Feinendegen LE; Heiniger HJ
    Hoppe Seylers Z Physiol Chem; 1972 May; 353(5):705-6. PubMed ID: 5069277
    [No Abstract]   [Full Text] [Related]  

  • 10. [Reutilization of tritiated thymidine and tritiated iododeoxyuridine for the synthesis of nuclear and mitochondrial DNA in regenerating rat liver].
    Baugnet-Mahieu L; Goutier R; Baes C
    Arch Int Physiol Biochim; 1971 Oct; 79(4):819-20. PubMed ID: 4110224
    [No Abstract]   [Full Text] [Related]  

  • 11. Blood thymidine level and iododeoxyuridine incorporation and reutilization in DNA in mice given long-acting thymidine pellets.
    Lee DJ; Prensky W; Krause G; Hughes WL
    Cancer Res; 1976 Dec; 36(12):4577-83. PubMed ID: 1000502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reutilization of 131I-5-iodo-2'-deoxyuridine as compared to 3H-thymidine in mouse duodenum and mammary tumor.
    Dethlefsen LA
    J Natl Cancer Inst; 1970 Apr; 44(4):827-40. PubMed ID: 11515050
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of 60 Co gamma radiation on the distribution, catabolism and incorporation of 125 I-5-iodo-2'-deoxyuridine into intestinal and splenic deoxyribonucleic acid in mice.
    Johanson KJ
    Acta Radiol Ther Phys Biol; 1972 Dec; 11(6):556-65. PubMed ID: 4661523
    [No Abstract]   [Full Text] [Related]  

  • 14. Double labeling with [3H]thymidine and [125I]iododeoxyuridine as a method for determining the fate of injected DNA and cells in vivo.
    Myers DK; Feinendegen LE
    J Cell Biol; 1975 Nov; 67(2PT.1):484-8. PubMed ID: 1194358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3H-5-iodo-2'-deoxyuridine toxicity. Problems in cell proliferation studies.
    Dethlefsen LA
    Cell Tissue Kinet; 1974 May; 7(3):213-22. PubMed ID: 4837671
    [No Abstract]   [Full Text] [Related]  

  • 16. Cell loss from several types of solid murine tumour: comparison of 125I-iododeoxyuridine and tritiated thymidine methods.
    Begg AC
    Cell Tissue Kinet; 1977 Sep; 10(5):409-27. PubMed ID: 922795
    [No Abstract]   [Full Text] [Related]  

  • 17. THE COMPARATIVE UPTAKE OF I-125-LABELED 5-IODO-2'-DEOXYURIDINE AND THYMIDINE-H3 INTO TISSUES OF MICE BEARING HEPATOMA-129.
    FOX BW; PRUSOFF WH
    Cancer Res; 1965 Feb; 25():234-40. PubMed ID: 14264056
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of radiation-sensitizing agents in radiation therapy of mouse mammary carcinoma.
    Suit HD; Hewitt R; Urano M
    Radiology; 1970 Jan; 94(1):189-95. PubMed ID: 5410341
    [No Abstract]   [Full Text] [Related]  

  • 19. INCORPORATION OF I-125-LABELED IODODEOXYURIDINE INTO THE DEOXYRIBONUCLEIC ACID OF MURINE AND HUMAN TISSUES FOLLOWING THERAPEUTIC DOSES.
    CLIFTON KH; SZYBALSKI W; HEIDELBERGER C; GOLLIN FF; ANSFIELD FJ; VERMUND H
    Cancer Res; 1963 Dec; 23():1715-23. PubMed ID: 14082864
    [No Abstract]   [Full Text] [Related]  

  • 20. Radiotoxicity of intranuclear tritium, 125 iodine and 131 iodine.
    Hofer KG; Hughes WL
    Radiat Res; 1971 Jul; 47(1):94-101. PubMed ID: 5559387
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.